SB214 updates Maryland’s cannabis and alcohol enforcement laws to address the sale and distribution of tetrahydrocannabinol (THC) products, especially intoxicating hemp-derived products and other nontraditional cannabinoid items. The bill defines THC broadly to include delta-8, delta-9, delta-10, and other intoxicating cannabinoids identified by the Cannabis Administration, and it sets limits on when products intended for human consumption or inhalation may be sold or distributed. In general, products with more than specified THC thresholds may only be sold by properly licensed cannabis businesses and must comply with state manufacturing, testing, packaging, and labeling standards.
The bill also creates a new prohibition on selling or distributing THC products that violate potency, packaging, or labeling rules, or that are advertised as containing unlawful amounts of THC. It authorizes the Executive Director of the Alcohol, Tobacco, and Cannabis Commission to seize, destroy, or confiscate unlawful products offered for sale in unlicensed locations. For non-licensees, violations can be charged by citation and punished as misdemeanors with fines up to $5,000; cannabis licensees are instead subject to administrative discipline. The bill also makes the display or offering of THC products prima facie evidence of sale in certain prosecutions, and it expands enforcement authority for the Field Enforcement Division to issue citations for specified criminal-law violations.
SB214 further reinforces age restrictions by barring sales of certain THC products to anyone under 21 and by requiring websites selling delta-8 or delta-10 products to use age-verification tools. It also preserves a narrow exception for hemp-derived tinctures that meet specific cannabidiol-to-THC ratios and potency limits, provided samples are submitted for testing as required by the Administration. The bill amends both the Alcoholic Beverages and Cannabis Article and the Criminal Law Article, and it takes effect July 1, 2025.
The overall sentiment reflected in the voting history appears strongly supportive, with the bill passing the Senate unanimously and the House by a substantial margin. No committee transcript excerpts were provided, so there is no recorded floor or committee debate to identify detailed arguments for or against the measure. Based on the bill’s structure, the support likely centered on consumer protection, youth access prevention, and closing regulatory gaps around intoxicating hemp products.
The main points of contention likely involve how broadly THC is defined, the regulatory burden on hemp and cannabinoid businesses, and the scope of enforcement powers given to the Commission. The bill distinguishes between licensed cannabis operators and unlicensed sellers, which may affect retailers, hemp-derived product vendors, and online sellers differently. The hemp-derived tincture exception and the testing requirement suggest an effort to balance industry access with public safety, but those provisions could still be a focus of debate among hemp businesses, cannabis licensees, and regulators.
SB214 amends the Maryland Alcoholic Beverages and Cannabis Article and the Criminal Law Article to create new restrictions and enforcement tools for THC-containing products. It establishes potency, packaging, labeling, and age-based sales limits for certain cannabinoid products, authorizes citations and misdemeanor penalties for non-licensees, subjects licensees to administrative discipline, and expands the Field Enforcement Division’s authority to enforce THC-related offenses. It also creates a narrow hemp-derived tincture exception and requires age verification for online sales of delta-8 and delta-10 products.
The bill appears to have enjoyed broad bipartisan support, as reflected by unanimous Senate passage and a wide House margin. With no committee transcript excerpts available, there is no direct record of objections or amendments in discussion, but the voting pattern suggests the measure was viewed favorably as a consumer-protection and enforcement bill. The general tone implied by the final enactment is that lawmakers agreed on the need to regulate intoxicating THC products more tightly.
The likely areas of contention are the breadth of the THC definition, the treatment of hemp-derived products, and the new enforcement and seizure authority. Retailers and hemp-product sellers may view the bill as restricting lawful commerce and increasing compliance costs, while cannabis regulators and public-safety advocates are likely to support tighter controls to prevent youth access and mislabeled products. The distinction between licensed cannabis businesses and unlicensed sellers, along with the exception for certain tinctures, suggests the bill tries to draw regulatory lines that may still be disputed by affected industries.